Adrhim Pharmaceuticals Llp Profile
Key Indicators
- Obligation of Contribution ₹ 2.00 Cr
- Company Age 7 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.34 Cr
- Revenue Growth 661.05%
- Profit Growth 116.96%
- Ebitda 41.67%
- Total Assets 16.71%
About Adrhim Pharmaceuticals Llp
Adrhim Pharmaceuticals Llp (APL) is 7 Year, 10 Months old Limited Liability Partnership 07 April 2017. Its registered office is in Gandhi Nagar, Gujarat, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 2.00 Cr as per MCA.
Company Details
- Location
Gandhi Nagar, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN/FCRN
AAJ-0957
- Incorporation Date
07 Apr 2017
- Date of Accounts and Solvency Statement
31 Mar 2023
- ROC Code
Roc-Ahmedabad
- Company Classification
Limited Liability Partnership
Industry
Who are the key members and board of directors at Adrhim Pharmaceuticals Llp?
Designated Partners (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dineshkumar Patel  | Designated Partner | 07-Apr-2017 | Current |
| Himanshukumar Patel | Designated Partner | 07-Apr-2017 | Current |
Financial Performance of Adrhim Pharmaceuticals Llp.
Adrhim Pharmaceuticals Llp, for the financial year ended 2021, experienced significant growth in revenue, with a 661.05% increase. The company also saw a substantial improvement in profitability, with a 116.96% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adrhim Pharmaceuticals Llp?
Unlock access to Adrhim Pharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sthapatya Realty LlpDineshkumar Patel is a mutual person
- Raghunath Colchem Private Limited
Dineshkumar Patel is a mutual person
- D C B Procon Private Limited
Dineshkumar Patel is a mutual person
Charges (Loans)
₹5.34 Cr
₹0
Charges Breakdown by Lending Institutions
- Small Industries Development Bank Of India : 2.84 Cr
- Sidbi : 2.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Oct 2021 | Sidbi | ₹2.50 Cr | Open |
| 24 Jul 2019 | Small Industries Development Bank Of India | ₹2.84 Cr | Open |
How Many Employees Work at Adrhim Pharmaceuticals Llp?
Unlock and access historical data on people associated with Adrhim Pharmaceuticals Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adrhim Pharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adrhim Pharmaceuticals Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.